Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCymaBay Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.73 | -$0.73 | -$0.73 |
| Q2 2025 | 2 | -$0.57 | -$0.57 | -$0.57 |
| Q3 2025 | 2 | -$0.53 | -$0.53 | -$0.53 |
| Q4 2025 | 3 | -$0.69 | -$0.69 | -$0.69 |
| Q1 2026 | 2 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2026 | 2 | -$0.20 | -$0.20 | -$0.20 |
CymaBay Therapeutics, Inc. Earnings Date And Information
CymaBay Therapeutics, Inc. last posted its earnings results on Wednesday, February 28th, 2024. The company reported $-0.35 earnings per share for the quarter, missing analysts' consensus estimates of $-0.32 by $0.03. The company had revenue of 57.00 K for the quarter and had revenue of 31.07 M for the year. CymaBay Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.99 diluted earnings per share) and currently has a price-to-earnings ratio of -32.74. CymaBay Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, May 12th, 2024 based on prior year's report dates.
CymaBay Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/28/2024 | Q4 2023 | -$0.32 | -$0.37 | -0.05 | $425.00 K | $57.00 K |
| 11/07/2023 | Q3 2023 | -$0.30 | -$0.32 | -0.02 | $222.22 K | $0 |
| 08/10/2023 | Q2 2023 | -$0.21 | -$0.01 | 0.2 | $11.00 M | $31.02 M |
| 05/15/2023 | Q1 2023 | -$0.16 | -$0.36 | -0.2 | $24.40 M | $0 |
| 03/23/2023 | Q4 2022 | N/A | -$0.41 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$0.30 | -$0.33 | -0.03 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$0.30 | -$0.36 | -0.06 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.31 | -$0.36 | -0.05 | N/A | $0 |
| 03/17/2022 | Q4 2021 | -$0.36 | -$0.38 | -0.02 | $6.43 M | $0 |
| 11/10/2021 | Q3 2021 | -$0.29 | -$0.33 | -0.04 | $6.25 M | $0 |
| 08/12/2021 | Q2 2021 | -$0.27 | -$0.34 | -0.07 | N/A | $0 |
| 05/13/2021 | Q1 2021 | -$0.24 | -$0.25 | -0.01 | N/A | $0 |
| 03/25/2021 | Q4 2020 | -$0.20 | -$0.23 | -0.03 | N/A | $0 |
| 11/05/2020 | Q3 2020 | -$0.17 | -$0.17 | 0 | N/A | $0 |
| 08/10/2020 | Q2 2020 | -$0.23 | -$0.16 | 0.07 | N/A | $0 |
| 05/11/2020 | Q1 2020 | -$0.31 | -$0.19 | 0.12 | N/A | $0 |
| 03/16/2020 | Q4 2019 | N/A | -$0.43 | N/A | N/A | $0 |
| 11/05/2019 | Q3 2019 | -$0.37 | -$0.38 | -0.01 | N/A | $0 |
| 08/07/2019 | Q2 2019 | -$0.37 | -$0.35 | 0.02 | N/A | $0 |
| 05/08/2019 | Q1 2019 | -$0.34 | -$0.37 | -0.03 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CymaBay Therapeutics, Inc. Earnings: FAQ's
CymaBay Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, May 12th, 2024 based offlast year's report dates.
The conference call for CymaBay Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for CymaBay Therapeutics, Inc.'s latest earnings report can be read online.
CymaBay Therapeutics, Inc. (:CBAY) has a recorded annual revenue of $31.07 M.
CymaBay Therapeutics, Inc. (:CBAY) has a recorded net income of $-105,370,000.CymaBay Therapeutics, Inc. has generated $-0.99 earnings per share over the last four quarters.
CymaBay Therapeutics, Inc. (:CBAY) has a price-to-earnings ratio of -32.74 and price/earnings-to-growth ratio is -0.33.